Peptide Science research editorial team.
Orforglipron 6mg x 90-Capsule Overview
Orforglipron (6mg x 90 Capsules = 540mg total) from Peptide Science is the encapsulated oral-format research preparation of the small-molecule non-peptide GLP-1 receptor agonist, supplied at 6 milligrams per capsule in a 90-count sealed bottle for preclinical animal-model incretin-pathway research.
Class and Mechanism in Preclinical Research
Orforglipron is a non-peptide small-molecule agonist of the GLP-1 receptor, structurally distinct from the synthetic peptide GLP-1 agonists (Semaglutide, Tirzepatide, Retatrutide) sold elsewhere in this catalogue. The small-molecule format gives the compound oral bioavailability without the enzymatic-degradation concerns that limit peptide GLP-1 analogs to injectable administration. Preclinical research has characterised the compound for biased agonism at the GLP-1 receptor, with reported downstream effects on incretin-pathway signalling in pancreatic and adipose cell-culture models. Browse the broader metabolic peptide range.
Per-Capsule Specifications
| Property | Value |
|---|---|
| Compound | Orforglipron (LY3502970) |
| Class | Non-peptide small-molecule GLP-1 receptor agonist |
| Strength per capsule | 6 mg |
| Pack count | 90 capsules per bottle (540 mg total) |
| Supplied form | Gelatin capsule, sealed bottle |
| Purity | greater than 99 percent (HPLC-MS verified) |
| Storage | Room temperature, sealed, dry; protect from light |
For the higher-strength 12 mg per-capsule format, see Orforglipron 12mg x 90 Capsules.
Handling and Stability
The sealed bottle stores at room temperature in a dry environment, with the desiccant pouch retained in the cap. For paired research with peptide GLP-1 receptor agonists, see Semaglutide 6mg or Tirzepatide 10mg.
Quality and Shipping
Each batch passes HPLC and mass spectrometry at greater than 99 percent purity. A Certificate of Analysis accompanies every order. Material is prepared in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in standard sealed packaging.
For laboratory research and development use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease, including obesity or type 2 diabetes. Has not been evaluated by the U.S. Food and Drug Administration. Branded therapeutic GLP-1 medicines are prescription-only and are not the same as research-grade compounds. Purchasers acknowledge they are qualified researchers age 21 or older.
Reviews
There are no reviews yet.